skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Limitations in the use of /sup 14/C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhea

Journal Article · · J. Clin. Gastroenterol.; (United States)

Analysis of a modified /sup 14/C-glycocholate breath test on 165 consecutive in-patients being investigated for chronic diarrhea showed that the measurement of /sup 14/CO/sub 2/ between 3 and 6 h after oral dosing of 5 microCi of /sup 14/C-glycocholic acid was of only limited use to distinguish between patients with Crohn's disease (CD), idiopathic bile salt wastage (IBW), or ileal resection (IR) from those with the irritable bowel syndrome (IBS). Continuing /sup 14/CO/sub 2/ collections for up to 24 h was of little more help in establishing the presence of bacterial overgrowth syndrome (BOS) and in distinguishing between BOS and CD. Stool bile acid measurements were of use in differentiating between IBW and IBS, but did not distinguish between CD and BOS or between CD and IR. Since the range of normal values was defined by measurements in the IBS group, a positive test was specific for an organic cause of chronic diarrhea. Even so, the sensitivity of the test was relatively low: CD, 53%; IR, 23%; IBW, /sup 14/%; and BOS, 10%. We believe that the 24-h /sup 14/C-glycocholic breath test combined with the measurement of stool bile acids represents a screening test of only limited use for the identification of organic causes of chronic diarrhea.

Research Organization:
Univ. of Alberta, Edmonton
OSTI ID:
5094411
Journal Information:
J. Clin. Gastroenterol.; (United States), Journal Name: J. Clin. Gastroenterol.; (United States)
Country of Publication:
United States
Language:
English